Visualized macrophage dynamics and significance of S100A8 in obese fat

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 16, 2015, Pages E2058-E2066

  Sekimoto, Ryohei ^a   Fukuda, Shiro ^a   Maeda, Norikazu ^a   Tsushima, Yu ^a   Matsuda, Keisuke ^a   Mori, Takuya ^a   Nakatsuji, Hideaki ^a   Nishizawa, Hitoshi ^a   Kishida, Ken ^a   Kikuta, Junichi ^a,b   Maijima, Yumiko ^a,b   Funahashi, Tohru ^a   Ishii, Masaru ^a,b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adipose tissue; Inflammation; Macrophage; Obesity; S100A8

Indexed keywords

ANTIBODY; CALGRANULIN A; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; INSULIN; LIPOPOLYSACCHARIDE; LYSOZYME; MESSENGER RNA; S100A8 PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; BLOOD; CHEMOTAXIS; DRUG EFFECTS; EPIDIDYMIS; GENETICS; INFLAMMATION; LIPID DIET; MACROPHAGE; MALE; METABOLISM; MOUSE; MULTIPHOTON MICROSCOPY; OBESITY; PATHOLOGY; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSITY; ANIMALS; ANTIBODIES; CALGRANULIN A; CHEMOTAXIS; DIET, HIGH-FAT; EPIDIDYMIS; GREEN FLUORESCENT PROTEINS; INFLAMMATION; INSULIN; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; MURAMIDASE; OBESITY; RNA, MESSENGER; UP-REGULATION;

EID: 84928229913     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409480112     Document Type: Article

References (34)

1. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115(5):1111-1119.
2. Badman MK, Flier JS (2005) The gut and energy balance: Visceral allies in the obesity wars. Science 307(5717):1909-1914.
3. Gesta S, Tseng YH, Kahn CR (2007) Developmental origin of fat: Tracking obesity to its source. Cell 131(2):242-256.
4. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24(1):29-33.
5. Xu H, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-1830.
6. Weisberg SP, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796-1808.
7. Murano I, et al. (2008) Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res 49(7):1562-1568.
8. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175-184.
9. Nishimura S, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15(8):914-920.
10. DeFuria J, et al. (2013) B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA 110(13):5133-5138.
11. Talukdar S, et al. (2012) Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 18(9):1407-1412.
12. Wu D, et al. (2011) Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332(6026):243-247.
13. Kanda H, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116(6): 1494-1505.
14. Weisberg SP, et al. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116(1):115-124.
15. Park JS, et al. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279(9):7370-7377.
16. Vogl T, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13(9):1042-1049.
17. Foell D, Wittkowski H, Vogl T, Roth J (2007) S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81(1):28-37.
18. Shi H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116(11):3015-3025.
19. Lee JY, et al. (2004) Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279(17):16971-16979.
20. Miller YI, et al. (2003) Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 278(3):1561-1568.
21. Schaefer L, et al. (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115(8): 2223-2233.
22. Faust N, Varas F, Kelly LM, Heck S, Graf T (2000) Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96(2):719-726.
23. Nishimura S, et al. (2008) In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118(2):710-721.
24. Fujiu K, Manabe I, Nagai R (2011) Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 121(9):3425-3441.
25. Huber J, et al. (2008) CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab 93(8):3215-3221.
26. Nara N, et al. (2007) Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem 282(42):30794-30803.
27. Hiuge-Shimizu A, et al. (2011) Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone. Arterioscler Thromb Vasc Biol 31(4):792-799.
28. Sekimoto R, et al. (2012) High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice. Biochem Biophys Res Commun 419(4):782-789.
29. Catalán V, et al. (2011) Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med 17(11-12):1157-1167.
30. Nakatsuji H, Kishida K, Funahashi T, Shimomura I; Senri Study II Group (2012) Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity. Diabetes Res Clin Pract 95(3):e58-e60.
31. Maeda N, et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8(7):731-737.
32. Ishii M, et al. (2009) Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458(7237):524-528.
33. Kikuta J, et al. (2013) Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc Natl Acad Sci USA 110(17):7009-7013.
34. Maeda N, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50(9):2094-2099.